Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Androgel in Diabetic Hypogonadism
NCT00440440Phase 4Withdrawn
- Sponsor
- Diabetes Center of the Southwest
- Start
- Aug 2009
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Testosterone TEPI patch in Hypogonadism, sponsored by Diabetes Center of the Southwest. Planned start Aug 2009; status: withdrawn.
02
Drugs
Testosterone TEPI patch
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT00440440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00440440.